UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000000974
Receipt number R000001169
Scientific Title A randomized phase II study designed to compare toxicity and dose intensity between four-week versus three-week schedule of gemcitabine for advanced pancreatic cancer
Date of disclosure of the study information 2008/01/08
Last modified on 2008/01/08 19:45:24

No. Disposal Last modified on Item of update
1 Insert 2008/01/08 19:47:40